NMDP

What NMDP does

NMDP is a global nonprofit organization focused on cell therapy, formerly known as Be The Match. It operates the world's largest bone marrow and cord blood registry, functioning as a central intermediary that connects patients requiring life-saving cell transplants with matched donors and cord blood units. Its primary served segment is healthcare providers and patients needing bone marrow transplants, stem cell therapy, and other cell therapy treatments. The organization's core value proposition is solving the donor-matching problem for cell therapy at scale, addressing the pain point of finding compatible biological material for patients facing time-critical transplant needs.

The organization's business model reflects its nonprofit status. NMDP generates revenue through a diversified mix typical of large health-focused nonprofits, including donor contributions, service fees charged to transplant centers and hospitals for search and cell procurement, cord blood unit sales, and grants from government and philanthropic sources. Pricing details and specific revenue mechanics are not disclosed in the source data. No named products, modules, or branded technology offerings are detailed beyond the general nonprofit identity and registry operations.

The technical footprint appears centered on registry infrastructure — donor recruitment, HLA typing, search algorithms, and logistics for cell transport — rather than a discrete software product. No API, SDK, or app is disclosed. The recent rebranding from Be The Match to NMDP signals a strategic repositioning toward a broader cell therapy mission beyond marrow matching, though the source data provides limited detail on near-term operational changes accompanying the rebrand.

Name

NMDP

Legal name

NMDP

Website

https://nmdp.org

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

NMDP is a global nonprofit cell therapy organization that operates the world's largest bone marrow and cord blood registry, connecting patients needing cell transplants with matched donors and treatment providers.

Ownership category

akta.pro rank

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Core offering

NMDP is a global nonprofit organization that operates the world's largest bone marrow and cord blood registry to connect patients with life-saving cell transplants. The organization facilitates cell therapy and bone marrow transplant services by linking patients with matched donors and supporting healthcare providers in delivering these treatments.

Product overview

NMDP is a global nonprofit organization in cell therapy, operating the world's largest bone marrow and cord blood registry to connect patients with life-saving cell transplants. Based on the source data provided, no specific named products, modules, or branded offerings are detailed beyond the general nonprofit identity.

Differentiator

Problem solved

Functional benefit

Products and services

• Bone marrow and cord blood donor registry The world's largest bone marrow and cord blood registry, connecting patients requiring cell therapy and bone marrow transplants with matched donors. Serves patients, donors, and healthcare providers globally.
• Cell therapy and bone marrow transplant services Cell therapy and bone marrow transplant services supporting patients in need of stem cell or bone marrow transplants, and the healthcare providers delivering these treatments.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights2 records

Direct peers

• DKMS: DKMS operates one of the largest international bone marrow donor registries, recruiting volunteers and facilitating matched unrelated donor transplants worldwide. It is the most direct functional peer to NMDP, competing in the same donor registry and cell therapy logistics space.
• Anthony Nolan: Anthony Nolan runs a major bone marrow and stem cell donor registry serving primarily UK and international patients, matching donors with recipients for life-saving transplants. Its registry-based operating model and nonprofit structure closely mirror NMDP's core activity.
• Gift of Life Bone Marrow Foundation: Gift of Life operates a bone marrow donor registry in the United States, recruiting volunteers and coordinating transplants for patients globally. It is a focused, smaller-scope peer to NMDP in volunteer donor matching and registry management.

Emerging players

• Adaptimmune: Adaptimmune is a clinical-stage cell therapy company developing engineered T-cell receptor therapies for cancer. As an emerging player in cell therapy, it represents the expanding universe of indications that could eventually intersect with NMDP's transplant and donor matching services.
• Allogene Therapeutics: Allogene is developing allogeneic (donor-derived) CAR-T cell therapies, a modality that may both complement and compete with traditional bone marrow transplant workflows. It is an emerging player whose trajectory signals the broader direction of the cell therapy field NMDP serves.

Broad incumbents

• American Red Cross: The American Red Cross collects, processes, and distributes biological products including blood components, operating a large donor-driven nonprofit infrastructure comparable in scale and mission orientation to NMDP. It is a broad incumbent adjacent to bone marrow and cord blood banking.
• Kite Pharma (Gilead): Kite Pharma develops and manufactures autologous CAR-T cell therapies, operating within the same broader cell therapy category NMDP serves. It represents the therapeutic-product side of the cell therapy ecosystem that ultimately drives demand for transplant matching services.
• Novartis Cell & Gene Therapy (Kymriah): Novartis markets Kymriah, a leading CAR-T cell therapy, and is a major incumbent in cell and gene therapy. Its commercial scale and pipeline signal the growth of cell-based treatments that increase the strategic importance of donor registries like NMDP's.

Others

• World Marrow Donor Association (WMDA): WMDA is the global umbrella organization coordinating standards and information exchange between bone marrow donor registries and cord blood banks. It is a strategic ecosystem partner that shapes the operating environment in which NMDP's registry functions.
• Leukemia & Lymphoma Society: LLS is a major nonprofit funder of blood cancer research and patient services. It shares NMDP's transplant-patient beneficiary base and influences demand for cell therapy through research funding and patient navigation, making it a strategically adjacent ecosystem player.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/nmdp_org
• Facebookfacebook.com/nmdporg
• LinkedInlinkedin.com/company/nmdp

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NMDP